PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Alborzinia, H.* ; Chen, Z.* ; Yildiz, U.* ; Freitas, F.P.* ; Vogel, F.C.E.* ; Varga, J.P.* ; Batani, J.* ; Bartenhagen, C.* ; Schmitz, W.* ; Büchel, G.* ; Michalke, B. ; Zheng, J. ; Meierjohann, S.* ; Girardi, E.* ; Espinet, E.* ; Flórez, A.F.* ; Dos Santos, A.F.* ; Aroua, N.* ; Cheytan, T.* ; Haenlin, J.* ; Schlicker, L.* ; Xavier da Silva, T.N.* ; Przybylla, A.* ; Zeisberger, P.* ; Superti-Furga, G.* ; Eilers, M.* ; Conrad, M. ; Fabiano, M.* ; Schweizer, U.* ; Fischer, M.* ; Schulze, A.* ; Trumpp, A.* ; Friedmann Angeli, J.P.*

LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastoma.

EMBO Mol. Med. 15:e18014 (2023)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Ferroptosis has emerged as an attractive strategy in cancer therapy. Understanding the operational networks regulating ferroptosis may unravel vulnerabilities that could be harnessed for therapeutic benefit. Using CRISPR-activation screens in ferroptosis hypersensitive cells, we identify the selenoprotein P (SELENOP) receptor, LRP8, as a key determinant protecting MYCN-amplified neuroblastoma cells from ferroptosis. Genetic deletion of LRP8 leads to ferroptosis as a result of an insufficient supply of selenocysteine, which is required for the translation of the antiferroptotic selenoprotein GPX4. This dependency is caused by low expression of alternative selenium uptake pathways such as system Xc- . The identification of LRP8 as a specific vulnerability of MYCN-amplified neuroblastoma cells was confirmed in constitutive and inducible LRP8 knockout orthotopic xenografts. These findings disclose a yet-unaccounted mechanism of selective ferroptosis induction that might be explored as a therapeutic strategy for high-risk neuroblastoma and potentially other MYCN-amplified entities.
Impact Factor
Scopus SNIP
Altmetric
11.100
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Ferroptosis ; Neuroblastoma ; Selenocysteine ; Selenoprotein ; Synthetic Lethality; Glutathione-peroxidase 4; Selenoprotein-p; Selenium Uptake; Ferroptosis; Gpx4; Inactivation; Dependency; Activation; Pathway
Sprache englisch
Veröffentlichungsjahr 2023
HGF-Berichtsjahr 2023
ISSN (print) / ISBN 1757-4676
e-ISSN 1757-4684
Zeitschrift EMBO Molecular Medicine
Quellenangaben Band: 15, Heft: 8, Seiten: , Artikelnummer: e18014 Supplement: ,
Verlag Wiley
Verlagsort Chichester
Begutachtungsstatus Peer reviewed
Institut(e) Research Unit BioGeoChemistry and Analytics (BGC)
Institute of Metabolism and Cell Death (MCD)
POF Topic(s) 30202 - Environmental Health
30203 - Molecular Targets and Therapies
Forschungsfeld(er) Environmental Sciences
Genetics and Epidemiology
PSP-Element(e) G-504800-002
G-506900-001
Förderungen Deutsche Forschungsgemeinschaft (DFG)
European Research Council (ERC) under the European Union
Junior Group Leader program of the Rudolf Virchow Center, University of Wurzburg
SPP2306
CRC205
FOR2674
SFB873 - Deutsche Forschungsgemeinschaft
"RiskY-AML"
Junior Group Leader program of the Rudolf Virchow Center
"Integrate-TN" Consortium - Deutsche Krebshilfe
Dietmar Hopp Foundation
Humboldt Postdoctoral Fellowship
FOR2314
Foerderverein fur~krebskranke Kinder e.V. Koln
German Ministry of Science and Education (BMBF) as part of the e:Med initiative
Austrian Academy of Sciences
European Research Council
Marie Sklodowska-Curie fellowship
University of Wurzburg
DOI 10.15252/emmm.202318014
WOS ID 001026953100001
Scopus ID 85164789894
PubMed ID 37435859
Erfassungsdatum 2023-10-06
[➜Korrektur melden]